February 24, 2021This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s…
February 24, 2017Those identified to have a potential increased risk for memory loss caused by Alzheimer’s disease were referred from the APT…
The ACTC repository is under review for potential modification in compliance with Administration directives.
Follow us on:
